Codimol CV (200+125) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Gujarat Terce Laboratories Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Clavulanic Acid, Cefpodoxime Proxetil. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 240 (arround $3.36 US Dollar)
Generic (Salt) Combination :
(Clavulanic Acid+ Cefpodoxime Proxetil)
Pharma Company :
Gujarat Terce Laboratories Ltd.
Brand Label :
Codimol CV (200+125)
Preparation Type :
Tablet
Single Dose :
1 Tablet
Composition (Fixed-Dose Combination) :
Clavulanic Acid-125 mg
Cefpodoxime Proxetil-200 mg
Pack Size/Qty/Vol :
10 Tablet
Price Unit :
Rs 24 INR (arround $0.336 US Dollar)
Price Pack :
Rs 240 INR (arround $3.36 US Dollar)
Drug details for Codimol CV (200+125)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Codimol CV (200+125) are :
Clavulanic Acid-125 mg
Cefpodoxime Proxetil-200 mg
Clavulanic Acid Indication (Prescribed for or used as):
For more details on Clavulanic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanic Acid..
Cefpodoxime Proxetil Indication (Prescribed for or used as):
For more details on Cefpodoxime Proxetil, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Cefpodoxime Proxetil..
Codimol CV (200+125) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 17 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Codimol CV (200+125), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Clavulanic Acid-125 mg Cefpodoxime Proxetil-200 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.